Renal Resistive Index As a Predictor of Acute Renal Impairment in High-risk Patients

Last updated: February 20, 2025
Sponsor: Aswan University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Kidney Disease

Kidney Failure

Renal Failure

Treatment

N/A

Clinical Study ID

NCT06386796
Asw.U./867/11/23
  • Ages 18-80
  • All Genders

Study Summary

To study the ability of RRI, measured by bedside Doppler ultrasound, in detecting acute kidney injury in high-risk patients admitted to surgical intensive care unit, Aswan university hospital, compared with renal biomarkers and conventional assessment using urine output and serum creatinine levels.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with severe pre-eclampsia and eclampsia.

  • Polytraumatized patients.

  • Patients admitted to ICU with sepsis.

  • Both genders.

  • Patients above 18 years.

Exclusion

Exclusion Criteria:

  • patients known to have CKD.

  • patients with congenital renal anomalies.

  • patients with renal transplantation.

Study Design

Total Participants: 100
Study Start date:
April 01, 2024
Estimated Completion Date:
June 06, 2025

Study Description

Acute kidney injury (AKI) is a common clinical problem encountered in critically ill patients, frequently in the setting of multiple organ failure, and is an independent risk factor for increase hospital stay and mortality risk.

Early-stage acute kidney injury was first assessed based on the risk, injury, failure, loss and end-stage (RIFLE) criteria in 2004, and then by the Acute Kidney Injury Network (AKIN) criteria in 2007. The Kidney Disease: Improving Global Outcomes (KDIGO) classification, based on both the AKIN and RIFLE criteria, was introduced in 2012, offering an assessment based on baseline creatinine and urine output.

The best strategy in clinical practice is to identify AKI as early as possible, reverse its cause, and even improve the sequelae. In the past decades, several serum creatinine (SCr)-based classification systems have been proposed to define AKI.

The limitations of SCr is that the determinants of SCr (rate of production, apparent volume of distribution, and rate of elimination) are variable. Therefore, there is an unmet need for other objective measures to help detect AKI in a timely manner. The role of several biomarkers in the early prediction or risk assessment of AKI has been proposed, including kidney tubular damage markers (e.g., neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM- 1), liver-type fatty acid-binding protein (L-FABP) and cystatin C).

Cystatin C is a protein from the family of cysteine proteinase inhibitors and is of interest as an early marker of decreased renal function. It is a protein that is synthesized at a constant rate by all cells containing nuclei, secreted into biological fluids: plasma, pleural, ascitic, cerebrospinal fluid, freely filtered through the glomerular membrane (due to its low molecular weight), fully metabolized in the kidneys, not secreted by the proximal renal tubules.

Renal resistive index (RRI) is a noninvasive instrument to evaluate kidney hemodynamics, and it is obtained by analysis of intrarenal arterial waves using Doppler ultrasound.

Connect with a study center

  • Aswan University

    Aswan, 81528
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.